Clinical research - Press Releases

Date	Title	Company
30-Jul-2021	The world’s first study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine (Sputnik Light) in Azerbaijan shows no serious adverse events or COVID infection cases following the vaccination	Russian Direct Investment Fund
29-Jul-2021	Significant Improvements in Survival and Developmental Milestones Demonstrated in Type 1 SMA Patients Treated with Evrysdi™	PTC Therapeutics, Inc.
28-Jul-2021	Incidence of very rare thromboembolic events was far lower than in people diagnosed with COVID-19 infection	AstraZeneca
27-Jul-2021	Bone & Cancer Cachexia Exacerbates Bone Resorption in Cancer Patients	Karl Landsteiner University of Health Sciences in Krems
27-Jul-2021	Pistoia Alliance Bridges the Gap Between User Experience and Digital Transformation with New Set of Heuristics	The
27-Jul-2021	Biogen and Eisai Announce ADUHELM™ (aducanumab-avwa) Data Presentations at Alzheimer’s Association International Conference 2021	Biogen and Eisai
26-Jul-2021	CHARNWOOD MOLECULAR AND SOLITEK LAUNCH A COLLABORATION COMBINING EXPERTISE IN DRUG DISCOVERY AND DEVELOPMENT	Smarter Marketing
23-Jul-2021	Bone & Cancer: Cachexia Exacerbates Bone Resorption in Cancer Patients	Karl Landsteiner University of Health Sciences (KL Krems)
23-Jul-2021	Fieldfisher publishes white paper - The future of medicine: Cell and gene therapy	Fieldfisher
23-Jul-2021	Global Anti-Infective Vaccines Market Research Report Up to 2031	Visiongain Ltd.
22-Jul-2021	Adoption of AI solutions and AI in Genomics Market Growth	Markets and Markets
22-Jul-2021	Increased R&D Investments in Pharmaceutical Industries Advancing The Lab Automation Market	Markets and Markets
22-Jul-2021	bluebird bio Receives EC Approval for SKYSONA™ (elivaldogene autotemcel, Lenti-D™) Gene Therapy for Patients Less Than 18 Years of Age With Early Cerebral Adrenoleukodystrophy (CALD) Without Matched Sibling Donor	bluebird bio
21-Jul-2021	ViiV Healthcare presents data from second Dovato (dolutegravir/lamivudine) switch study confirming non-inferior efficacy and no virologic failure versus a broad range of regimens of at least 3 drugs	ViiV Healthcare
20-Jul-2021	Rare Disease Therapeutics Market to grow at a Significant Rate During the Forecast Period \| TechSci Research	TechSci Research Pvt Ltd
19-Jul-2021	Growing Application Areas of Genomics - Gene Editing Market Developments	Markets and Markets
19-Jul-2021	US FDA approves fexinidazole as the first all-oral treatment for sleeping sickness	Sanofi
17-Jul-2021	CD BioSciences Introduces Randomization Plan Design Services for Clinical Research	CD BioSciences
17-Jul-2021	Amerigo Scientific Launches New AcrB Transporter for Therapeutic Indications	Amerigo Scientific
17-Jul-2021	STEMart Launches Genetic Toxicology Testing Services for Medical Devices	STEMart